Kyowa Hakko Committed to Successively Developing New Drugs: President Dr Matsuda

Referring to the NHI drug pricing system reform proposed by the JPMA on July 11 (see pages 8-9, PHARMA JAPAN No.2050), Yuzuru Matsuda, president and CEO of Kyowa Hakko Kogyo, reconfirmed at a press meeting on July 13 his company's...read more